Entropy Technologies LP Sells 64,719 Shares of UiPath Inc. (NYSE:PATH)

Entropy Technologies LP reduced its stake in shares of UiPath Inc. (NYSE:PATH - Free Report) by 33.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 128,578 shares of the healthcare company's stock after selling 64,719 shares during the quarter. Entropy Technologies LP's holdings in UiPath were worth $1,646,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in UiPath by 5.6% in the 1st quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company's stock valued at $911,741,000 after buying an additional 2,133,078 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in UiPath by 164.9% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 95,469 shares of the healthcare company's stock valued at $1,222,000 after buying an additional 59,435 shares during the period. State Board of Administration of Florida Retirement System boosted its holdings in shares of UiPath by 0.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company's stock worth $6,696,000 after purchasing an additional 1,571 shares during the period. Benjamin F. Edwards & Company Inc. boosted its stake in shares of UiPath by 3,389.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 89,189 shares of the healthcare company's stock valued at $1,131,000 after buying an additional 86,633 shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp grew its stake in UiPath by 4.2% in the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company's stock valued at $5,240,000 after purchasing an additional 9,393 shares in the last quarter. Institutional investors and hedge funds own 62.50% of the company's stock.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares in the company, valued at approximately $10,258,498.19. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 22.37% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

PATH has been the topic of a number of recent research reports. Barclays raised their price target on shares of UiPath from $14.00 to $15.00 and gave the company an "equal weight" rating in a report on Friday, September 6th. Evercore ISI boosted their price objective on UiPath from $13.00 to $16.00 and gave the stock an "in-line" rating in a research report on Friday, September 6th. DA Davidson raised their target price on UiPath from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Friday, September 6th. Royal Bank of Canada reiterated a "sector perform" rating and set a $16.00 price target on shares of UiPath in a report on Friday, September 6th. Finally, BMO Capital Markets raised their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock a "market perform" rating in a research note on Friday, September 6th. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $17.47.

UiPath Stock Up 3.4 %

Shares of NYSE PATH traded up $0.46 during midday trading on Wednesday, reaching $13.82. 5,671,604 shares of the company traded hands, compared to its average volume of 9,493,449. UiPath Inc. has a 12 month low of $10.37 and a 12 month high of $27.87. The stock's 50-day simple moving average is $12.59 and its 200-day simple moving average is $13.48.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The firm's quarterly revenue was up 10.0% on a year-over-year basis. During the same period last year, the firm posted ($0.09) EPS. As a group, equities research analysts expect that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.